Prognostic performance of the prediction model in a validation cohort of 41 TNBC patients.

Abstract

<p>A risk score was assigned to each patient as calculated by the prediction model. Based on the risk score, the patients were stratified into either the low-risk group or the high-risk group. Kaplan-Meier analysis and log-rank tests were used to determine the significant differences in survival between groups. (A) Differences in distant metastasis-free survival between low-risk and high-risk groups. (B) Differences in overall survival between low-risk and high-risk groups.</p